Author: Anthony Traurig
Regulatory report: delta-8 THC in the US
Written by Anthony Traurig || 19th May 2021 || Regulatory reports |
Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold ...
US Customs stands accused of seizing legal hemp – and farm machinery
Written by Anthony Traurig || 16th April 2021 || Regulatory briefing |
The US Customs and Border Protection (CBP) agency is wrongly seizing legal hemp and hemp-related shipments – such as farm equipment that it claims constitutes drug paraphernalia – according to two recently-filed lawsuits ...
Regulatory report: financial services for CBD companies in the US
Written by Anthony Traurig || 30th March 2021 || Regulatory reports |
This report addresses the reasons why CBD and cannabis-related businesses in the US have trouble obtaining banking and payment processing services, what they can do, and what might be done to address the problem ...
Governor’s influence questioned after judge blocks cannabis legalisation
Written by Anthony Traurig || 23rd February 2021 || Regulatory briefing |
The legalisation of recreational cannabis in South Dakota is in doubt, amidst accusations of political interference after a judge appointed by the state governor ruled the voter-approved amendment unconstitutional ...
Regulatory report: Canada
Written by Anthony Traurig || 8th February 2021 || Regulatory reports |
Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules ...
CBD product labelling – a US state-by-state analysis
Written by Anthony Traurig || 14th January 2021 || Regulatory reports , Regulatory trackers |
This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states' regulations as possible ...
Montana’s ballot initiative to legalise cannabis faces court challenge
Written by Anthony Traurig || 9th December 2020 || Regulatory briefing |
A move to legalise cannabis in the US state of Montana, backed by a substantial majority in last month’s ballot, is under threat from a legal bid to block it ...
Regulatory report: CBD in cosmetics – a US state-by-state report
Written by Anthony Traurig || 2nd December 2020 || Regulatory reports |
Cosmetics have been a mainstay in the CBD market in the US, and there are no signs that is likely to change any time soon. This report offers an overview of the current status of CBD in cosmetics...
Opponents unlikely to derail Arizona recreational cannabis legalisation
Written by Anthony Traurig || 20th November 2020 || Regulatory briefing |
Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear...
Can state governor overturn voters’ ‘wrong choice’ to legalise cannabis?
Written by Anthony Traurig || 18th November 2020 || Regulatory briefing |
Electors in South Dakota – not a traditionally cannabis-friendly state – voted overwhelmingly to legalise both medical and recreational cannabis. The governor doesn't like it – but is there anything she can do to stop it? ...
CBD in dietary supplements: alternative pathways to market under the US FDA
Written by Anthony Traurig || 12th November 2020 || Regulatory reports |
The US Food and Drug Administration (FDA) may be open to allowing CBD as an ingredient in dietary supplements as well as in food and drink products. However, the regulatory pathway is not clear ...